Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Anesth Analg ; 122(5): 1370-6, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-26859874

RESUMO

BACKGROUND: Ultralow doses of naloxone, an opioid and toll-like receptor 4 antagonist, blocked remifentanil-induced hyperalgesia and the associated increase in the minimum alveolar concentration (MAC), but not tolerance. The aim was to determine the effects of the toll-like receptor 4 antagonist, ibudilast, on the MAC in the rat and how it might prevent the effects of remifentanil. METHODS: Male Wistar rats were randomly allocated to 5 treatment groups (n = 7 per group): 10 mg/kg ibudilast intraperitoneally, 240 µg/kg/h remifentanil IV, ibudilast plus remifentanil, remifentanil plus naloxone IV, or saline. The sevoflurane MAC was determined 3 times in every rat and every day (days 0, 2, and 4): baseline (MAC-A) and 2 further determinations were made after treatments, 1.5 hours apart (MAC-B and MAC-C). RESULTS: A reduction in baseline MAC was produced on day 0 by ibudilast, remifentanil, remifentanil plus ibudilast, remifentanil plus naloxone (P < 0.01), but not saline. Similar effects were found on days 2 and 4. A tolerance to remifentanil was found on days 0, 2, and 4, which neither ibudilast nor naloxone prevented. The MAC increase produced by remifentanil on day 4 (P = 0.001) was prevented by either ibudilast or naloxone. CONCLUSIONS: Ibudilast, besides reducing the MAC, prevented the delayed increase in baseline MAC produced by remifentanil but not the increase in MAC caused by tolerance to remifentanil.


Assuntos
Analgésicos Opioides/farmacologia , Anestésicos Inalatórios/farmacologia , Comportamento Animal/efeitos dos fármacos , Éteres Metílicos/farmacologia , Limiar da Dor/efeitos dos fármacos , Piperidinas/farmacologia , Piridinas/farmacologia , Receptor 4 Toll-Like/antagonistas & inibidores , Administração por Inalação , Analgésicos Opioides/administração & dosagem , Analgésicos Opioides/toxicidade , Anestésicos Inalatórios/administração & dosagem , Animais , Interações Medicamentosas , Tolerância a Medicamentos , Injeções Intraperitoneais , Injeções Intravenosas , Masculino , Éteres Metílicos/administração & dosagem , Naloxona/farmacologia , Antagonistas de Entorpecentes/farmacologia , Piperidinas/administração & dosagem , Piperidinas/toxicidade , Piridinas/administração & dosagem , Ratos Wistar , Remifentanil , Sevoflurano , Fatores de Tempo
2.
Food Funct ; 10(11): 7325-7332, 2019 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-31641704

RESUMO

Herein, a supercritical extraction plant (with a 6 L extraction cell) was successfully used to obtain ergosterol-enriched extracts from Lentinula edodes under the following conditions: a temperature of 40 °C, pressure of 225 bar, reaction time of 1-5 h, and the flow rate of 20 L h-1 for recirculated CO2. Moreover, ergosterol (ERG) and the SFE extract (SFE) with highest ergosterol concentration were microemulsified and submitted to in vitro digestion to study their ability to displace cholesterol from dietary mixed micelles (DMMs). ERG was also mixed with a ß-glucan-enriched (33.5%) extract (BGE) obtained from L. edodes to investigate the synergies between them; the results indicated that all these extracts (including BGE without ERG) could reduce the cholesterol levels in the DMMs. However, when ERG and SFE were simultaneously administered to mice with a hypercholesterolemic diet, no significant differences in the serum cholesterol levels were detected as compared to the case of the control. However, when only BGE was administrated to another mice model previously induced with hypercholesterolemia, significant reduction in the cholesterol levels was noticed.


Assuntos
Colesterol/sangue , Ergosterol/farmacologia , Cogumelos Shiitake , beta-Glucanas/farmacologia , Animais , Ergosterol/química , Carpóforos/química , Masculino , Camundongos , Camundongos Endogâmicos C57BL , beta-Glucanas/química
3.
Food Funct ; 9(12): 6360-6368, 2018 Dec 13.
Artigo em Inglês | MEDLINE | ID: mdl-30456394

RESUMO

Eritadenine is a hypocholesterolemic compound that is found in several mushroom species such as Lentinula edodes, Marasmius oreades, and Amanita caesarea (1.4, 0.7 and 0.6 mg per g dry weight, respectively). It was synthesized during all developmental stages, being present in higher concentrations in the skin of shiitake fruiting bodies. When subjected to traditional cooking, grilling followed by frying were more adequate methodologies than boiling or microwaving to maintain its levels. Modern culinary processes such as texturization (with agar-agar) and spherification (with alginate) also interfered with its release. Grilling and gelling using gelatin enhanced eritadenine's bioaccessibility in an in vitro digestion model. An animal model (where male and female rats were administered 21 and 10 mg per kg animal per day of eritadenine) indicated that intake of the compound was safe under these concentrations; it reached the liver and reduced the atherogenic index (TC/HDL) in rat sera. Thus, it might be used to design a functional food.


Assuntos
Adenina/análogos & derivados , Agaricales/química , Anticolesterolemiantes/metabolismo , Hipercolesterolemia/dietoterapia , Extratos Vegetais/metabolismo , Adenina/química , Adenina/metabolismo , Agaricales/metabolismo , Animais , Anticolesterolemiantes/química , Disponibilidade Biológica , Contenção de Riscos Biológicos , Culinária , Feminino , Humanos , Hipercolesterolemia/metabolismo , Masculino , Extratos Vegetais/química , Ratos , Ratos Sprague-Dawley
4.
Lab Anim ; 51(4): 365-375, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27694319

RESUMO

Unlike non-steroidal anti-inflammatory drugs (NSAIDs), metamizole has poor anti-inflammatory effects; and is suitable for models where analgesia, but not anti-inflammatory effects, is desirable. Like opioids, these drugs produce perioperative analgesia while reducing anaesthetic requirements, but it remains unclear whether they may develop tolerance or hyperalgesia, and thus decrease in analgesic efficacy. The aim was to determine whether tolerance or hyperalgesia to metamizole occurred in rats, and whether the sevoflurane minimum alveolar concentration (MAC) was affected. In a randomized, prospective, controlled study, male Wistar rats ( n = 8 per group) were administered metamizole (300 mg/kg, day 4). Previously, the following treatments were provided: daily metamizole for four days (0-3), morphine (10 mg/kg; positive control, day 0 only) or saline (negative control). The main outcome measures were mechanical (MNT) and warm thermal (WNT) nociceptive quantitative sensory thresholds. The baseline sevoflurane MAC and the reduction produced by the treatments were also determined. The mean (SD) baseline MAC [2.4(0.2)%vol] was decreased by morphine and metamizole by 45(11)% and 33(7)% ( P = 0.000, both), respectively. Baseline MNT [35.4(4.5) g] and WNT [13.2(2.4) s] were decreased by morphine and metamizole: MNT reduction of 22(6)% ( P = 0.000) and 22(7)% ( P = 0.001), respectively and WNT reduction of 34(14)% ( P = 0.000) and 24(13)% ( P = 0.001). The baseline MAC on day 4 was neither modified by treatments nor the MAC reduction produced by metamizole (days 0 and 4; P > 0.05). In conclusion, repeated metamizole administration may produce hyperalgesia, although it may not modify its anaesthetic sparing effect. The clinical relevance of this effect in painful research models requiring prolonged analgesic therapy warrants further investigation.


Assuntos
Dipirona/farmacologia , Hiperalgesia/veterinária , Éteres Metílicos/farmacocinética , Animais , Hiperalgesia/tratamento farmacológico , Masculino , Nociceptividade/efeitos dos fármacos , Limiar da Dor/efeitos dos fármacos , Estudos Prospectivos , Alvéolos Pulmonares/metabolismo , Distribuição Aleatória , Ratos , Ratos Wistar , Sevoflurano
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA